Vancouver, WA
Summary
This company specializes in biologics drug discovery, utilizing generative AI to create novel antibodies and biologics therapies. Their innovative approach allows for the design of antibodies from scratch, bypassing traditional methods that rely on existing libraries. By integrating AI with synthetic biology, they aim to streamline the drug creation process, reduce development timelines, and improve success rates in bringing new therapies to patients, particularly for challenging diseases.